<DOC>
	<DOCNO>NCT01778361</DOCNO>
	<brief_summary>Despite prevalence osteopenia osteoporosis HIV positive population , relatively little known underlie pathology . This prospective cohort study aim gain understanding number issue relate low bone mineral density HIV-infected subject .</brief_summary>
	<brief_title>HIV UPBEAT : Understanding Pathology Bone Disease HIV-infected Patients .</brief_title>
	<detailed_description>This study follow HIV positive negative subject annually 5 year . The aim study include : - describe pathology underlie low bone mineral density - ass relationship low bone mineral density antiretroviral therapy exposure - ass relationship low bone mineral density vitamin D /PTH status and/or marker bone metabolism - ass relationship osteopenia subsequent change bone mineral density marker bone metabolism - assess validity currently available fracture risk assessment tool predict fracture HIV positive population</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<criteria>age &gt; 18 year able provide write , informed consent able attend research centre fast state undergo DEXA scan Subjects bisphosphonate therapy screen Pregnant breastfeed female subject Subjects previous clinical history primary hyperthyroidism HIV negative subject elevate parathyroid hormone screen HIVnegative subject prior history osteoporosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Human immunodeficiency virus</keyword>
	<keyword>low bone mineral density</keyword>
	<keyword>osteopenia</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>fracture</keyword>
</DOC>